Daniel Farraye

Daniel Farraye

Goodwin

Contact
View Bio
RSS

Latest Posts › Biotechnology

Share:

Accord Biopharma Announces FDA Approval of IMULDOSA (ustekinumab-srlf)

​​​​​​​On October 14, 2024, Accord BioPharma, Inc. announced that the FDA has approved IMULDOSA (ustekinumab-srlf), a biosimilar to Johnson & Johnson’s STELARA (ustekinumab), indicated for the treatment of chronic...more

10/25/2024  /  Biotechnology , FDA Approval , Food and Drug Administration (FDA) , Life Sciences , Patents , Pharmaceutical Industry
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide